Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T05880
|
|||||
Target Name |
Gamma-secretase subunit APH-1A/1B (APH-1)
|
|||||
Synonyms |
Anterior pharynx-defective 1
Click to Show/Hide
|
|||||
Gene Name |
APH1A-APH1B
|
|||||
Target Type |
Patented-recorded target
|
[1] | ||||
Disease | [+] 2 Target-related Diseases | + | ||||
1 | Alzheimer disease [ICD-11: 8A20] | |||||
2 | Herpes simplex infection [ICD-11: 1F00] | |||||
Function |
The gamma-secretase complex plays a role in Notch and Wnt signaling cascades and regulation of downstream processes via its role in processing key regulatory proteins, and by regulating cytosolic CTNNB1 levels.
Click to Show/Hide
|
|||||
UniProt ID | ||||||
Sequence |
MTAAVFFGCAFIAFGPALALYVFTIATEPLRIIFLIAGAFFWLVSLLISSLVWFMARVII
DNKDGPTQKYLLIFGAFVSVYIQEMFRFAYYKLLKKASEGLKSINPGETAPSMRLLAYVS GLGFGIMSGVFSFVNTLSDSLGPGTVGIHGDSPQFFLYSAFMTLVIILLHVFWGIVFFDG CEKKKWGILLIVLLTHLLVSAQTFISSYYGINLASAFIILVLMGTWAFLAAGGSCRSLKL CLLCQDKNFLLYNQRSRMGAAVFFGCTFVAFGPAFALFLITVAGDPLRVIILVAGAFFWL VSLLLASVVWFILVHVTDRSDARLQYGLLIFGAAVSVLLQEVFRFAYYKLLKKADEGLAS LSEDGRSPISIRQMAYVSGLSFGIISGVFSVINILADALGPGVVGIHGDSPYYFLTSAFL TAAIILLHTFWGVVFFDACERRRYWALGLVVGSHLLTSGLTFLNPWYEASLLPIYAVTVS MGLWAFITAGGSLRSIQRSLLCRRQEDSRVMVYSALRIPPED Click to Show/Hide
|
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Patented Agent(s) | [+] 4 Patented Agents | + | ||||
1 | PMID28350212-Compound-18 | Drug Info | Patented | Alzheimer disease | [1] | |
2 | PMID28350212-Compound-19 | Drug Info | Patented | Alzheimer disease | [1] | |
3 | PMID28350212-Compound-20 | Drug Info | Patented | Alzheimer disease | [1] | |
4 | PMID28350212-Compound-7 | Drug Info | Patented | Herpes simplex virus infection | [1] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Inhibitor | [+] 18 Inhibitor drugs | + | ||||
1 | PMID28350212-Compound-1 | Drug Info | [1] | |||
2 | PMID28350212-Compound-12 | Drug Info | [1] | |||
3 | PMID28350212-Compound-13 | Drug Info | [1] | |||
4 | PMID28350212-Compound-15 | Drug Info | [1] | |||
5 | PMID28350212-Compound-16 | Drug Info | [1] | |||
6 | PMID28350212-Compound-18 | Drug Info | [1] | |||
7 | PMID28350212-Compound-19 | Drug Info | [1] | |||
8 | PMID28350212-Compound-20 | Drug Info | [1] | |||
9 | PMID28350212-Compound-21 | Drug Info | [1] | |||
10 | PMID28350212-Compound-22 | Drug Info | [1] | |||
11 | PMID28350212-Compound-23 | Drug Info | [1] | |||
12 | PMID28350212-Compound-24 | Drug Info | [1] | |||
13 | PMID28350212-Compound-25 | Drug Info | [1] | |||
14 | PMID28350212-Compound-30 | Drug Info | [1] | |||
15 | PMID28350212-Compound-35 | Drug Info | [1] | |||
16 | PMID28350212-Compound-36 | Drug Info | [1] | |||
17 | PMID28350212-Compound-7 | Drug Info | [1] | |||
18 | Sulfonamide derivative 15 | Drug Info | [2] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Gamma secretase inhibitors: a patent review (2013 - 2015).Expert Opin Ther Pat. 2017 Jul;27(7):851-866. | |||||
REF 2 | Cancer stem cell (CSC) inhibitors: a review of recent patents (2012-2015).Expert Opin Ther Pat. 2017 Jul;27(7):753-761. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.